Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

NCT00064220 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: soblidotin

Sponsor

Daiichi Sankyo

Collaborators

[object Object]